- Home
- CC vs XENE Comparison
CC vs XENE Comparison
Compare CC & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CC | XENE |
|---|---|---|
| Founded | 2014 | 1996 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 3.2B |
| IPO Year | 2014 | 2014 |
Fundamental Metrics
Financial Performance| Metric | CC | XENE |
|---|---|---|
| Price | $23.47 | $57.30 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 9 | 12 |
| Target Price | $19.78 | ★ $67.17 |
| AVG Volume (30 Days) | ★ 2.5M | 944.8K |
| Earning Date | 05-05-2026 | 05-11-2026 |
| Dividend Yield | ★ 1.51% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,638,000,000.00 | $311,000.00 |
| Revenue This Year | $6.15 | N/A |
| Revenue Next Year | $5.95 | $2,436.26 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 7.36 | N/A |
| 52 Week Low | $9.13 | $28.19 |
| 52 Week High | $24.13 | $62.91 |
Technical Indicators
Market Signals| Indicator | CC | XENE |
|---|---|---|
| Relative Strength Index (RSI) | 64.84 | 54.82 |
| Support Level | $20.51 | $39.93 |
| Resistance Level | N/A | $59.44 |
| Average True Range (ATR) | 1.04 | 1.87 |
| MACD | 0.05 | -0.32 |
| Stochastic Oscillator | 78.26 | 32.47 |
Price Performance
Historical ComparisonAbout CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.